These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 27593973)

  • 1. Does Dose to an Oral Mucosa Organ at Risk Predict the Duration of Grade 3 Mucositis after Intensity-modulated Radiotherapy for Oropharyngeal Cancer?
    Yahya S; Benghiat H; Nightingale P; Tiffany M; Sanghera P; Hartley A
    Clin Oncol (R Coll Radiol); 2016 Dec; 28(12):e216-e219. PubMed ID: 27593973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of oral mucosa dose and volume parameters with Grade 3 mucositis, in patients treated with volumetric modulated arc radiotherapy for oropharyngeal cancer?
    Bansal A; Bedi N; Kaur R; Singh G; Benipal RPS; Dangwal V
    Jpn J Clin Oncol; 2023 Mar; 53(4):313-320. PubMed ID: 36546704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Weekly dose-volume parameters of mucosa and constrictor muscles predict the use of percutaneous endoscopic gastrostomy during exclusive intensity-modulated radiotherapy for oropharyngeal cancer.
    Sanguineti G; Gunn GB; Parker BC; Endres EJ; Zeng J; Fiorino C
    Int J Radiat Oncol Biol Phys; 2011 Jan; 79(1):52-9. PubMed ID: 20418027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of radiotherapy and chemotherapy on the risk of mucositis during intensity-modulated radiation therapy for oropharyngeal cancer.
    Sanguineti G; Sormani MP; Marur S; Gunn GB; Rao N; Cianchetti M; Ricchetti F; McNutt T; Wu B; Forastiere A
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):235-42. PubMed ID: 22104358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of mucositis in oropharyngeal and oral cavity cancer in patients treated with volumetric modulated radiation treatment: A dose-volume analysis.
    Mazzola R; Ricchetti F; Fersino S; Fiorentino A; Giaj Levra N; Di Paola G; Ruggieri R; Alongi F
    Head Neck; 2016 Apr; 38 Suppl 1():E815-9. PubMed ID: 25920015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dosimetric advantages of intensity-modulated proton therapy for oropharyngeal cancer compared with intensity-modulated radiation: A case-matched control analysis.
    Holliday EB; Kocak-Uzel E; Feng L; Thaker NG; Blanchard P; Rosenthal DI; Gunn GB; Garden AS; Frank SJ
    Med Dosim; 2016; 41(3):189-94. PubMed ID: 27158021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multivariable model for predicting acute oral mucositis during combined IMRT and chemotherapy for locally advanced nasopharyngeal cancer patients.
    Orlandi E; Iacovelli NA; Rancati T; Cicchetti A; Bossi P; Pignoli E; Bergamini C; Licitra L; Fallai C; Valdagni R; Cavallo A
    Oral Oncol; 2018 Nov; 86():266-272. PubMed ID: 30409311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proton therapy and oral mucositis in oral & oropharyngeal cancers: outcomes, dosimetric and NTCP benefit.
    Nangia S; Gaikwad U; Noufal MP; Sawant M; Wakde M; Mathew A; Chilukuri S; Sharma D; Jalali R
    Radiat Oncol; 2023 Jul; 18(1):121. PubMed ID: 37468950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A dosimetric planning study comparing intensity-modulated radiotherapy with four-field conformal pelvic radiotherapy for the definitive treatment of cervical carcinoma.
    Forrest J; Presutti J; Davidson M; Hamilton P; Kiss A; Thomas G
    Clin Oncol (R Coll Radiol); 2012 May; 24(4):e63-70. PubMed ID: 21752614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can dosimetric parameters predict acute hematologic toxicity in rectal cancer patients treated with intensity-modulated pelvic radiotherapy?
    Wan J; Liu K; Li K; Li G; Zhang Z
    Radiat Oncol; 2015 Aug; 10():162. PubMed ID: 26238572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dosimetric Evaluation of Different Intensity-Modulated Radiotherapy Techniques for Breast Cancer After Conservative Surgery.
    Zhang F; Wang Y; Xu W; Jiang H; Liu Q; Gao J; Yao B; Hou J; He H
    Technol Cancer Res Treat; 2015 Oct; 14(5):515-23. PubMed ID: 25311257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative analysis of the factors which affect the interpatient organ-at-risk dose sparing variation in IMRT plans.
    Yuan L; Ge Y; Lee WR; Yin FF; Kirkpatrick JP; Wu QJ
    Med Phys; 2012 Nov; 39(11):6868-78. PubMed ID: 23127079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dosimetric benefits of intensity-modulated radiotherapy and volumetric-modulated arc therapy in the treatment of postoperative cervical cancer patients.
    Deng X; Han C; Chen S; Xie C; Yi J; Zhou Y; Zheng X; Deng Z; Jin X
    J Appl Clin Med Phys; 2017 Jan; 18(1):25-31. PubMed ID: 28291936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is IMAT the ultimate evolution of conformal radiotherapy? Dosimetric comparison of helical tomotherapy and volumetric modulated arc therapy for oropharyngeal cancer in a planning study.
    Servagi Vernat S; Ali D; Puyraveau M; Viard R; Lisbona A; Fenoglietto P; Bedos L; Makovicka L; Giraud P
    Phys Med; 2014 May; 30(3):280-5. PubMed ID: 23948367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is pulmonary artery a dose-limiting organ at risk in non-small cell lung cancer patients treated with definitive radiotherapy?
    Ma JT; Sun L; Sun X; Xiong ZC; Liu Y; Zhang SL; Huang LT; Han CB
    Radiat Oncol; 2017 Feb; 12(1):34. PubMed ID: 28143532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose and extended-field intensity modulated radiation therapy for early-stage NK/T-cell lymphoma of Waldeyer's ring: dosimetric analysis and clinical outcome.
    Bi XW; Li YX; Fang H; Jin J; Wang WH; Wang SL; Liu YP; Song YW; Ren H; Dai JR
    Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):1086-93. PubMed ID: 24120822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dosimetric comparison between jaw tracking and static jaw techniques in intensity-modulated radiotherapy.
    Feng Z; Wu H; Zhang Y; Zhang Y; Cheng J; Su X
    Radiat Oncol; 2015 Jan; 10():28. PubMed ID: 25623899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring dosimetric impact of weight loss with kilovoltage (kV) cone beam CT (CBCT) during parotid-sparing IMRT and concurrent chemotherapy.
    Ho KF; Marchant T; Moore C; Webster G; Rowbottom C; Penington H; Lee L; Yap B; Sykes A; Slevin N
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):e375-82. PubMed ID: 22197229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dosimetric predictors of radiation-induced acute nausea and vomiting in IMRT for nasopharyngeal cancer.
    Lee VH; Ng SC; Leung TW; Au GK; Kwong DL
    Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):176-82. PubMed ID: 22245210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interfractional dose variations in the stomach and the bowels during breathhold intensity-modulated radiotherapy for pancreatic cancer: Implications for a dose-escalation strategy.
    Nakamura A; Shibuya K; Nakamura M; Matsuo Y; Shiinoki T; Nakata M; Mizowaki T; Hiraoka M
    Med Phys; 2013 Feb; 40(2):021701. PubMed ID: 23387724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.